Funding round
Kallyope Series A
Kallyope, which works in neurological disease therapeutics discovery in New York, raised $44M in a Series A round announced on 10 Dec 2015, led by Lux Capital. 5 firms took part, with 1 individual investor. It is Kallyope's first venture round on record.
$44M
Amount raised
Not disclosed
Post-money valuation
5
Investors
1 lead
Valuation
What this round says about the price
Kallyope did not disclose a valuation in this round. It is Kallyope's first venture round on record, in the year it was founded (2015). It is 9.6% of the $458M Kallyope has raised in the venture rounds on record. Kallyope raised again 26 months later: a Series B round of $66M in Feb 2018. Its next priced round, a Series D in Feb 2022, valued it at $1.30B.
Investors
Who put money in
Lux Capital led the round with 4 other firms.
Lead investor
- Lux Capital backs 194 venture-backed companies new investor
Also in the round
- backs 98 venture-backed companies new investor
- backs 24 venture-backed companies new investor
- backs 38 venture-backed companies new investor
- Alexandria Venture Investments new investor
Individual investors: Tony Evnin.
Use of proceeds
What the money is for
According to the announcement, the money goes to hiring, product development, sales and marketing, scaling operations and working capital.
- Hiring
- Product development
- Sales and marketing
- Scaling operations
- Working capital
Comparable rounds
How it compares
14 Series A rounds in Biotechnology within a year either side disclosed an amount; the median was $13M, and this round was 3.5 times the median. The closest in time, other companies' Series A rounds in Biotechnology:
| Company | Announced | Amount | Post-money | Led by |
|---|---|---|---|---|
| Biotechnology | 15 Dec 2015 | $11M | not disclosed | Inkef and Aglaia Oncology Funds |
| Biotechnology | 14 Oct 2015 | $22M | not disclosed | Ysios Capital |
| Biotechnology | 29 Sep 2015 | $31M | not disclosed | Sofinnova Partners |
| Biotechnology | 22 Mar 2016 | $16M | not disclosed | Epidarex |
| Biotechnology | 11 May 2016 | $13M | not disclosed | Oxford Science Enterprises |
| Biotechnology | 10 Jul 2015 | $12M | not disclosed | not named |
| Biotechnology | 22 Jul 2015 | undisclosed | not disclosed | not named |
| Biotechnology | 2 Jun 2016 | $12M | not disclosed | Arboretum Ventures and Baird Capital |
Sources
Where this comes from
Reported by 4 sources.
Questions
Frequently asked
How much did Kallyope raise in its Series A round?
Kallyope raised $44M in its Series A round, announced in Dec 2015.
Who led Kallyope's Series A round?
Lux Capital led it, with Polaris Partners, The Column Group, Illumina Ventures and Alexandria Venture Investments.
What was Kallyope's valuation at the Series A round?
It was not disclosed.
How does it compare with other Series A rounds in Biotechnology?
14 Series A rounds in Biotechnology within a year either side disclosed an amount; the median was $13M, and this round was 3.5 times the median.
Did Kallyope raise again after this round?
Yes: a Series B round in Feb 2018 of $66M.